Table 3 Baseline characteristics of the remission group and the non-remission group.
From: Hyperuricemia remission after colorectal cancer surgery for colorectal cancer patients
Characteristics | Remission (34) | Non-remission (57) | P value |
|---|---|---|---|
Age, year | 63.0 ± 12.9 | 64.1 ± 10.7 | 0.646 |
Sex | 0.849 | ||
Male | 12 (35.3%) | 19 (33.3%) | |
Female | 22 (64.7%) | 38 (66.7%) | |
Hypertension | 17 (50.0%) | 26 (45.6%) | 0.685 |
T2DM | 2 (5.9%) | 6 (10.5%) | 0.705 |
Weight preoperative, kg | 61.9 ± 11.5 | 60.9 ± 10.2 | 0.671 |
BMI preoperative, kg/m2 | 23.8 ± 3.9 | 24.2 ± 3.0 | 0.582 |
Smoking | 9 (26.5%) | 15 (26.3%) | 0.987 |
Drinking | 5 (14.7%) | 16 (28.1%) | 0.143 |
Albumin, g/L | 41.0 ± 4.3 | 41.3 ± 4.9 | 0.766 |
Hemoglobin, g/L | 124.9 ± 24.3 | 124.2 ± 20.3 | 0.888 |
Tumor location | 0.218 | ||
Colon | 17 (50.0%) | 21 (36.8%) | |
Rectum | 17 (50.0%) | 36 (63.2%) | |
Tumor stage | |||
I | 7 (20.6%) | 18 (31.6%) | 0.431 |
II | 16 (47.1%) | 16 (28.1%) | |
III | 11 (32.4%) | 11 (19.3%) | |
Tumor size | 0.828 | ||
< 5 cm | 24 (70.6%) | 39 (68.4%) | |
≥ 5 cm | 10 (29.4%) | 18 (31.6%) | |
